HAOHAI BIOTEC (06826): Multifocal aspheric intraocular lens products have obtained medical device registration certificates.

date
18:59 07/04/2026
avatar
GMT Eight
Haohai Biotechnology (06826) announced that its wholly-owned subsidiary Shanghai Haohai Biotechnology Co., Ltd. ("the Company") recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the National Medical Products Administration for its multifocal non-spherical artificial crystalline lens product (hereinafter referred to as "the product") produced by Henan Universe Artificial Crystalline Lens Research Co., Ltd.
HAOHAI BIOTEC (06826) announced that its wholly-owned subsidiary, Henan Universe Artificial Crystalline Lens Research Co., Ltd. (hereinafter referred to as the "Company"), recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the National Medical Products Administration for its multifocal non-spherical artificial crystalline lens product (hereinafter referred to as "this product"). This product is the world's first multifocal artificial crystalline lens based on the patented technology of FOURSEMI harmonic five-focus diffraction, which can achieve more efficient light energy distribution, improve light energy utilization, and enhance the visual acuity of traditional trifocal artificial crystalline lens, making the vision in the far intermediate area, intermediate distance area, and intermediate near area more continuous and smooth. The approval of this product further enhances the company's product layout in high-end artificial crystalline lenses. The company has formed a complete matrix covering ordinary spherical single-focus products to high-end multifocal and continuous range artificial crystalline lens products, which will help enhance the company's competitiveness in the high-end refractive cataract field and promote the development of domestic artificial crystalline lenses towards higher technological levels and higher added value.